Shenyang Sinqi Ophthalmic Medications Holdings Co., Ltd. (hereinafter referred to as “Sinqi Ophthalmic Medications”) is a state-level high-tech company located in Qipan Mountain, Shenyang City. It covers a floor area of about 76,000 square meters and specializes in the R & D, production and sales of ophthalmic medications. The company went public on the Shenzhen Stock Exchange GEM (Stock: Sinqi Ophthalmic Medications; Stock Code: 300573) on December 8, 2016. Sinqi Ophthalmic Medications has been committed to promoting eye health, and has been applying the corporate philosophy - “responsibility, innovation, perseverance, and devotion” – to its services for the eye care industry. At present, the company provides ten categories of quality ophthalmic medications including ophthalmic anti-infectives, ophthalmic anti-inflammatory agents, mydriatics and cycloplegia drugs, ophthalmic non-steroidal anti-inflammatory drugs, miotics and anti-glaucoma drugs.
Innovation is the driving force behind Sinqi Ophthalmic Medications to grow from strength to strength. The company has a provincial-level enterprise technology center and a provincial-level ophthalmic medication engineering technology research center. It has also established an ophthalmic drug R & D platform for conventional ophthalmic preparations, instant gels, sustained-release preparations, compatibility testing for drug packaging materials, ophthalmic pharmacodynamics, pharmacokinetics and toxicology and has developed comprehensive capabilities for ophthalmic medication R & D and innovation.
Design emphasizes quality and fastidious attention to details is essential to quality products. The Qipan Mountain Factory of Sinqi Ophthalmic Medications was put into production in 2014. It was designed in accordance with US FDA and EU GMP standards and was jointly founded by a world-class design team, equipment suppliers and construction companies. It has production lines for calf blood extractives, single-dose eye drops, multi-dose eye drops, ophthalmic gel, ophthalmic solution and inner packaging materials for ophthalmic medications etc.
Sinqi Ophthalmic Medications focuses on drugs R & D and production, takes a market-oriented approach and draws on close communication and cooperation with domestic and international research institutions, medical institutions and ophthalmology experts, to promote innovation-driven growth, accelerate the transformation of scientific research results and improve the capability for academic advancement. Sinqi Ophthalmic Medications has developed a comprehensive marketing system, has established partnerships with hundreds of distributors and has extended its sales network across provincial, municipal and county-level medical institutions throughout China.
We have been customer-centric in serving China’s eye care industry.
We rely on our diligent employees and also strive to facilitate personal fulfillment.
We put shareholders’ interest first and make every effort to satisfy investors.
Changes and improvements never end at Sinqi Ophthalmic Medications, which goes all out to create long-term values for its customers, employees, shareholders and the society and shoulders the mission of promoting Chinese medicine based on continuous self-improvement. The vision of “establishing itself as a globally competitive ophthalmic medication researcher and manufacturer” has spurred the company on to further progress.
Sinqi Ophthalmic Medications will keep developing and delivering in China but also reach out to the world.